SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003738
Filing Date
2021-11-09
Accepted
2021-11-09 16:08:41
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q janx-20210930.htm   iXBRL 10-Q 2578988
2 EX-10.1 janx-ex10_1.htm EX-10.1 272658
3 EX-31.1 janx-ex31_1.htm EX-31.1 19260
4 EX-31.2 janx-ex31_2.htm EX-31.2 18052
5 EX-32.1 janx-ex32_1.htm EX-32.1 17156
6 GRAPHIC img14736707_0.jpg GRAPHIC 49867
  Complete submission text file 0000950170-21-003738.txt   8698866

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT janx-20210930_pre.xml EX-101.PRE 314201
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT janx-20210930_def.xml EX-101.DEF 196441
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT janx-20210930.xsd EX-101.SCH 44359
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT janx-20210930_cal.xml EX-101.CAL 41208
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT janx-20210930_lab.xml EX-101.LAB 424681
12 EXTRACTED XBRL INSTANCE DOCUMENT janx-20210930_htm.xml XML 1419091
Mailing Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037
Business Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037 858-750-4700
Janux Therapeutics, Inc. (Filer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40475 | Film No.: 211392169
SIC: 2834 Pharmaceutical Preparations